Judge Won’t Sign Consent Decree Between Lilly, Medical Centers In Trademark Dispute
SEATTLE — Eli Lilly and Co., two medical centers and two of their physicians who prescribe patients compounded versions of tirzepatide XE "tirzepatide" , a U.S. Food and Drug Administration-approved drug...To view the full article, register now.
Already a subscriber? Click here to view full article